Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Pharm Dev Technol. 2013 May-Jun;18(3):701-9. doi: 10.3109/10837450.2012.705298. Epub 2012 Jul 20.
Pilocarpine is used topically in the treatment of glaucoma. Various studies were performed to improve the bioavailability and prolong the residence time of drugs in ocular drug delivery. Drug loaded polymeric and lipid nanoparticles offer several favourable biological properties, such as biodegradability, nontoxicity, biocompatibility and mucoadhesiveness. Therefore, preparing positively-charged pilocarpine HCl-loaded polymeric and lipid nanoparticles was the purpose of this study. Nanoparticles were prepared by quasi-emulsion solvent evaporation technique. The non-biodegradable positively-charged polymer Eudragit(®) RS 100 and semi-solid lipid excipient Gelucire(®) 44/14 were used as a vehicle, the cationic lipid octadecylamine was used as a cationic agent. The formulations were evaluated in terms of particle size, size distribution, zeta potential measurement, thermal behavior (Differential Scanning Calorimetry DSC), entrapment efficacy and pH. Characterizations of nanoparticles were analyzed during the storage period of 6 months for stability tests. Polymeric and lipid nanoparticles could be prepared successfully promising their use for ophthalmic delivery.
匹鲁卡品被局部用于治疗青光眼。为了提高药物在眼部给药中的生物利用度和延长药物的驻留时间,进行了各种研究。载药聚合物和脂质纳米粒具有生物降解性、无毒性、生物相容性和粘膜粘附性等多种有利的生物学特性。因此,本研究的目的是制备带正电荷的盐酸匹鲁卡品载药聚合物和脂质纳米粒。纳米粒通过准乳液溶剂蒸发技术制备。非生物降解的带正电荷的聚合物 Eudragit(®) RS 100 和半固体脂质赋形剂 Gelucire(®) 44/14 用作载体,十八胺用作阳离子剂。根据粒径、粒径分布、Zeta 电位测量、热行为(差示扫描量热法 DSC)、包封效率和 pH 值对制剂进行评价。在 6 个月的储存期内对纳米粒进行稳定性测试,分析纳米粒的特性。成功制备了聚合物和脂质纳米粒,有望用于眼部给药。